South Korea

red blood cells

Biotech

Agios signs $165M deal for blood disorder drug that failed study

Days after its lead clinical-stage asset suffered a setback, Agios has rebounded by buying a blood disorder drug that flunked a phase 2 study.

James Waldron Jun 1, 2026 9:26am

Sketch of lungs

With $30M, Oorja Bio breathes new life into fibrosis candidate

May 20, 2026 10:31am

The flags of South Korea and the United States

Lilly pledges $500M to South Korea biopharma industry

Mar 10, 2026 12:00pm

Seoul South Korea

Roche pumps $480M into South Korea biopharma industry

Mar 4, 2026 11:22am

busy and colorful calendar

Sanofi signs 2nd biotech deal of the day

Dec 15, 2025 5:50pm

Heart on futuristic podium with neon lighting

Korean CRO inks collab to expand into organoids, transcriptomics

Jul 22, 2025 3:10pm